Description
| Product Name | Format | CAT.No | Size |
| CK-nac Nac Activation Serum Start, IFCC | Lyo | BXC0251B | R1: 1 x 105ml R2: 10 x 10ml |
| CK-nac Nac Activation Serum Start, IFCC | Lyo | BXC0251D | R1: 1 x 35ml R2: 10 x 2.5ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252A | R1: 2 x 25ml R2: 2 x 5ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252B | R1: 2 x 50ml R2: 2 x 10ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252C | R1: 6 x 10ml R2: 1 x 12ml |
| CK-nac 4+1 Nac Activation Serum Start, DGKC | LS | BXC0253A | R1: 2 x 20ml R2: 1 x 10ml |
| CK-nac 4+1 Nac Activation Serum Start, DGKC | LS | BXC0253B | R1: 2 x 40ml R2: 1 x 20ml |
Product Description
The Biorex Diagnostics CK-NAC Assay is a ready-to-use reagent system for the quantitative determination of total creatine kinase (CK) activity in human serum and plasma, providing essential insight into muscle and cardiac health. Creatine kinase is an intracellular enzyme found predominantly in skeletal muscle, cardiac muscle, and brain tissue, where it plays a key role in cellular energy metabolism. When muscle or cardiac cells are damaged, CK is released into the bloodstream, making it a valuable biomarker for detecting tissue injury. Measurement of CK activity is widely used in the diagnosis and monitoring of myocardial ischaemia, acute myocardial infarction, and skeletal muscle disorders.
Key Features
- Quantitative measurement of total CK activity in serum and plasma
- Clinically relevant for cardiac events, skeletal muscle disorders, and tissue injury assessment
- NAC-activated IFCC enzymatic method ensures high accuracy, sensitivity, and reproducibility
- Ready-to-use reagents simplify laboratory workflow and reduce preparation errors
- Compatible with automated analysers, kinetic assays, and manual laboratory methods
Benefits
The Biorex CK-NAC Assay delivers precise, reliable, and reproducible results, supporting diagnosis, patient monitoring, and research applications in cardiology and clinical biochemistry. Its NAC-activated IFCC methodology enhances enzyme activity measurement, ensuring consistent and accurate detection of CK levels across clinically relevant ranges. By providing dependable results, the assay supports clinicians in identifying muscle damage, assessing severity, and monitoring recovery or treatment response.
This assay is particularly valuable in hospital laboratories, emergency departments, cardiology units, and clinical chemistry settings where rapid assessment of tissue injury is required. Its ready-to-use format streamlines workflow, reduces pre-analytical variability, and ensures consistent performance across different laboratory environments. Compatibility with automated analysers allows seamless integration into routine testing platforms, supporting efficient, high-throughput analysis while maintaining accuracy and reliability.
In addition to clinical diagnostics, the Biorex CK-NAC Assay supports research into muscle physiology, cardiac injury mechanisms, and metabolic function, making it an essential tool for advancing understanding of tissue damage and improving patient outcomes.
Contact Us for more information.